Insider trading

Period: 12 months Stock: TARS Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

30 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

30 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

30 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

30 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
30 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
30 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

30 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold on a plan 2×
$942.64K 10,773 at 87.50
80.9%
Sold half or more
4 Sep 2026
Neervannan Seshadri Chief Operating Officer
Sold on a plan
$387.94K 4,564 at 85.00
5.5%
Planned (10b5-1)
4 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer · indirect
Sold on a plan 2×
$278.25K 3,180 at 87.50
66.7%
Sold half or more
2 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold on a plan
$430.96K 5,387 at 80.00
28.8%
Planned (10b5-1)
2 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer · indirect
Sold on a plan
$127.20K 1,590 at 80.00
25.0%
Planned (10b5-1)
1 Sep 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold on a plan
$339.83K 4,601 at 73.86
19.7%
Planned (10b5-1)
16 Jun 2026
Farrow Jeffrey S See Remarks
Sold at will
$877.44K 14,396 at 60.95
20.2%
Not planned
20 Mar 2026
Neervannan Seshadri Chief Operating Officer
Sold on a plan
$199.52K 2,989 at 66.75
3.5%
Planned (10b5-1)
19 Mar 2026
Neervannan Seshadri Chief Operating Officer
Sold at will
$307.46K 4,589 at 67.00
5.1%
Not planned
19 Mar 2026
Mottiwala Aziz Chief Commercial Officer
Sold at will
$297.48K 4,440 at 67.00
6.7%
Not planned
19 Mar 2026
Wahl Bryan General Counsel
Sold at will
$283.48K 4,231 at 67.00
6.2%
Not planned
19 Mar 2026
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$279.66K 4,174 at 67.00
10.6%
Not planned
19 Mar 2026
Farrow Jeffrey S See Remarks
Sold at will
$146.46K 2,186 at 67.00
4.8%
Not planned
19 Mar 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold at will
$26.13K 390 at 67.00
1.6%
Not planned
18 Mar 2026
Mottiwala Aziz Chief Commercial Officer
Sold at will
$297.51K 4,330 at 68.71
6.2%
Not planned
18 Mar 2026
Wahl Bryan General Counsel
Sold at will
$283.43K 4,125 at 68.71
5.7%
Not planned
18 Mar 2026
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$279.72K 4,071 at 68.71
9.4%
Not planned
18 Mar 2026
Neervannan Seshadri Chief Operating Officer
Sold at will
$248.04K 3,610 at 68.71
3.8%
Not planned
18 Mar 2026
Farrow Jeffrey S See Remarks
Sold at will
$146.56K 2,133 at 68.71
4.5%
Not planned
18 Mar 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold at will
$26.04K 379 at 68.71
1.6%
Not planned
17 Mar 2026
Mottiwala Aziz Chief Commercial Officer
Sold at will
$297.53K 4,286 at 69.42
5.8%
Not planned
17 Mar 2026
Wahl Bryan General Counsel
Sold at will
$283.51K 4,084 at 69.42
5.3%
Not planned
17 Mar 2026
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$279.69K 4,029 at 69.42
8.5%
Not planned
17 Mar 2026
Neervannan Seshadri Chief Operating Officer
Sold at will
$216.94K 3,125 at 69.42
3.2%
Not planned
17 Mar 2026
Farrow Jeffrey S See Remarks
Sold at will
$146.55K 2,111 at 69.42
4.2%
Not planned
17 Mar 2026
Lin Elizabeth Yeu Chief Medical Officer
Sold at will
$26.03K 375 at 69.42
1.5%
Not planned
4 Mar 2026
Neervannan Seshadri Chief Operating Officer
Sold on a plan
$641.42K 8,366 at 76.67
10.6%
Planned (10b5-1)
2 Jan 2026
Whitfield Dianne C. Chief Human Resources Officer
Sold on a plan 4×
$1.26M 15,565 at 80.67
40.0%
Planned (10b5-1)
16 Dec 2025
Whitfield Dianne C. Chief Human Resources Officer
Sold on a plan
$592.50K 7,397 at 80.10
16.0%
Planned (10b5-1)
16 Dec 2025
Lin Elizabeth Yeu Chief Medical Officer
Sold at will
$165.20K 2,078 at 79.50
8.7%
Not planned
Showing 1–30 of 30.